-
How the Different COVID Vaccines Will Handle New Variants of the Virus
Companies are working on developing vaccines so they can handle emerging variants of COVID. Here’s how the approaches differ.
-
Op-Ed: Trust in Covid Vaccine Needs to Be Earned for Blacks and Latinos After Decades of Mistreatment
After decades of racist disinvestment and medical mistreatment, Black and Latino communities have every reason to be skeptical of the Covid vaccine.
-
Yes, You Can Take OTC Pain Meds After Getting the Covid Vaccine, Says CDC — Plus Other Tips for Dealing With Side Effects
What you can do, and what you shouldn’t do, when it comes to OTC medications and the Covid-19 vaccine.
-
Biden Says U.S. Will Seek to ‘End Cancer as We Know It' After Covid Pandemic
Biden said that two White House offices will be involved in developing an “advanced-research effort on cancer and other diseases.”
-
Biden Defends Progress on COVID as Weather Delays 6M Shots
President Joe Biden has toured a state-of-the art coronavirus vaccine plant
-
Coronavirus Vaccines: Here's What You Need to Know
The rollout of COVID-19 vaccines has been slower and more difficult than Americans had hoped, plagued by an undersupply that the Biden administration is trying to overcome. The new administration announced on Feb. 11 that it had finalized a deal to buy 200 million more doses of the Pfizer BioNTech and Moderna versions of the vaccine, the first to receive…
-
CDC to Investigate Death of Nebraska Man Who Received Covid Vaccine Dose
The CDC and FDA received 1,170 reports of death among individuals in the U.S. who received a Covid vaccine — 0.003% of vaccinated people — between Dec. 14, 2020, and Feb. 7, 2021.
-
Dr. Scott Gottlieb Says Vaccine Ramp Up Alone Probably Won't Be Enough to Manage UK Virus Variant
Travel restrictions might not make a big difference in the containment of B117, even if the Biden Administration were to impose them, Scott Gottlieb said.
-
UK Launches ‘World First' Trial Mixing Different Covid Vaccines for First and Second Doses
A trial is being launched in the U.K. to explore whether using different Covid-19 vaccines for the first and second doses works.
-
Pfizer Ahead of Schedule to Release 200 Million Doses of COVID-19 Vaccine
Pfizer announced on Tuesday that it is months ahead of schedule to deliver 200 million doses of its coronavirus vaccine to the U.S. The shipment should be available to Americans starting in May.
-
Operation Warp Speed Chief Resigns at Biden Team's Request, Will Stay Through Transition, Sources Say
The scientific leader of the U.S. vaccine effort will stay in the role for 30 days, but won’t be chief advisor as of Inauguration Day, sources say.
-
WATCH: Biden Receives Second Dose of Pfizer Vaccine
President-elect Joe Biden received his second dose of the Pfizer coronavirus vaccine on Monday. The president-elect also urged Americans to continue to wear masks and social distance as case numbers and the death toll continue to climb.
-
BioNTech Says Covid Vaccine Is Effective Against Key New Strains; to Publish More Data in Days
Public health experts have expressed concern the new mutant strains could pose a threat to inoculation efforts.
-
Dr. Scott Gottlieb: Getting Covid Vaccine Doesn't Mean People Can Just Return to Pre-Pandemic Life
“It’s not going to be like it was in 2017 and 2018, when we didn’t worry at all about catching a respiratory pathogen,” Dr. Scott Gottlieb told CNBC.
-
The UK Is Delaying Second Vaccine Shots and It's Proving Controversial. Here's What We Know So Far
The U.K.’s decision to delay giving people the second dose of a coronavirus vaccine is proving controversial, with experts and the vaccine producers weighing in.
-
Fast Rollout of Virus Vaccine Trials Reveals Tribal Distrust
Few Native American tribes have signed up to participate in clinical trials as coronavirus vaccines are developed
-
Fauci Warns of Post-Christmas Surge in Covid Infections
Fauci warns that coronavirus infections may get another boost as Americans flock together for Christmas and New Year’s celebrations.
-
S&P 500 Closes Flat, Giving Up Most of the Gains in the Final Minutes of Trading
President Donald Trump expressed concerns about the new Covid-19 relief package which could delay the deployment of funds to struggling Americans.
-
Treasury Yields Hold Steady After Congress Approves Coronavirus Relief Deal
U.S. government bond yields fell on Tuesday as investor sentiment was shaken by a fast-spreading new coronavirus strain in the U.K.
-
Hospital CEOs Say They Expect Skeptical Employees Will Want Covid Vaccine When They See Co-Workers Getting It
Hospital CEOs expressed confidence Thursday that the hesitancy among some employees around Covid-19 vaccinations will fade over time.